{
  "symbol": "AARTIDRUGS.NS",
  "period": "quarterly",
  "data": [
    {
      "ticker": "AARTIDRUGS.NS",
      "date": "2024-06-30",
      "quarter": "Q2 2024",
      "fiscal_year": 2024,
      "revenue": null,
      "gross_profit": null,
      "operating_income": null,
      "ebitda": null,
      "net_income": null,
      "diluted_eps": null,
      "total_assets": null,
      "total_liabilities": null,
      "total_equity": null,
      "total_debt": null,
      "cash_and_equivalents": null,
      "current_assets": null,
      "current_liabilities": null,
      "operating_cash_flow": null,
      "investing_cash_flow": null,
      "financing_cash_flow": null,
      "free_cash_flow": null,
      "capex": null,
      "pe_ratio": 18.838547,
      "peg_ratio": null,
      "pb_ratio": 2.757615,
      "ps_ratio": 1.5100992,
      "price_target_high": 597.0,
      "price_target_low": 597.0,
      "price_target_avg": 597.0,
      "promoter_holding": 0.60928,
      "institutional_holding": 0,
      "eps_estimate": null,
      "next_earnings_date": null,
      "last_buyback_date": null,
      "dividends": null,
      "splits": null,
      "buybacks": null,
      "debt_to_equity": null,
      "current_ratio": null,
      "operating_margin": null,
      "net_profit_margin": null,
      "roe": null,
      "roa": null,
      "debt_to_fcf_ratio": null,
      "ebitda_margin": null,
      "revenue_growth_yoy": null,
      "ebitda_growth_yoy": null
    },
    {
      "ticker": "AARTIDRUGS.NS",
      "date": "2024-09-30",
      "quarter": "Q3 2024",
      "fiscal_year": 2024,
      "revenue": 5983300000.0,
      "gross_profit": 2051800000.0,
      "operating_income": 533200000.0,
      "ebitda": 685300000.0,
      "net_income": 350100000.0,
      "diluted_eps": null,
      "total_assets": 24295500000.0,
      "total_liabilities": 11517610000.0,
      "total_equity": 12777890000.0,
      "total_debt": 5901000000.0,
      "cash_and_equivalents": 113400000.0,
      "current_assets": 12558800000.0,
      "current_liabilities": 7811100000.0,
      "operating_cash_flow": null,
      "investing_cash_flow": null,
      "financing_cash_flow": null,
      "free_cash_flow": null,
      "capex": null,
      "pe_ratio": 18.838547,
      "peg_ratio": null,
      "pb_ratio": 2.757615,
      "ps_ratio": 1.5100992,
      "price_target_high": 597.0,
      "price_target_low": 597.0,
      "price_target_avg": 597.0,
      "promoter_holding": 0.60928,
      "institutional_holding": 0,
      "eps_estimate": null,
      "next_earnings_date": null,
      "last_buyback_date": null,
      "dividends": null,
      "splits": null,
      "buybacks": null,
      "debt_to_equity": 0.46181333537853275,
      "current_ratio": 1.6078145203620489,
      "operating_margin": 8.911470258887237,
      "net_profit_margin": 5.851286079588188,
      "roe": 2.739888980105479,
      "roa": 1.4410075939988887,
      "debt_to_fcf_ratio": null,
      "ebitda_margin": 11.453545702204469,
      "revenue_growth_yoy": null,
      "ebitda_growth_yoy": null
    },
    {
      "ticker": "AARTIDRUGS.NS",
      "date": "2024-12-31",
      "quarter": "Q4 2024",
      "fiscal_year": 2024,
      "revenue": 5566000000.0,
      "gross_profit": 2052100000.0,
      "operating_income": 479300000.0,
      "ebitda": 736300000.0,
      "net_income": 370500000.0,
      "diluted_eps": null,
      "total_assets": null,
      "total_liabilities": null,
      "total_equity": null,
      "total_debt": null,
      "cash_and_equivalents": null,
      "current_assets": null,
      "current_liabilities": null,
      "operating_cash_flow": null,
      "investing_cash_flow": null,
      "financing_cash_flow": null,
      "free_cash_flow": null,
      "capex": null,
      "pe_ratio": 18.838547,
      "peg_ratio": null,
      "pb_ratio": 2.757615,
      "ps_ratio": 1.5100992,
      "price_target_high": 597.0,
      "price_target_low": 597.0,
      "price_target_avg": 597.0,
      "promoter_holding": 0.60928,
      "institutional_holding": 0,
      "eps_estimate": null,
      "next_earnings_date": null,
      "last_buyback_date": null,
      "dividends": null,
      "splits": null,
      "buybacks": null,
      "debt_to_equity": null,
      "current_ratio": null,
      "operating_margin": 8.611210923463888,
      "net_profit_margin": 6.656485806683435,
      "roe": null,
      "roa": null,
      "debt_to_fcf_ratio": null,
      "ebitda_margin": 13.228530362917715,
      "revenue_growth_yoy": null,
      "ebitda_growth_yoy": null
    },
    {
      "ticker": "AARTIDRUGS.NS",
      "date": "2025-03-31",
      "quarter": "Q1 2025",
      "fiscal_year": 2025,
      "revenue": 6586576000.0,
      "gross_profit": -1262446000.0,
      "operating_income": 903586000.0,
      "ebitda": 951908000.0,
      "net_income": 628585000.0,
      "diluted_eps": null,
      "total_assets": 25746782000.0,
      "total_liabilities": 12053354000.0,
      "total_equity": 13693428000.0,
      "total_debt": 6150707000.0,
      "cash_and_equivalents": 45772000.0,
      "current_assets": 13383550000.0,
      "current_liabilities": 8369668000.0,
      "operating_cash_flow": null,
      "investing_cash_flow": null,
      "financing_cash_flow": null,
      "free_cash_flow": null,
      "capex": null,
      "pe_ratio": 18.838547,
      "peg_ratio": null,
      "pb_ratio": 2.757615,
      "ps_ratio": 1.5100992,
      "price_target_high": 597.0,
      "price_target_low": 597.0,
      "price_target_avg": 597.0,
      "promoter_holding": 0.60928,
      "institutional_holding": 0,
      "eps_estimate": null,
      "next_earnings_date": null,
      "last_buyback_date": null,
      "dividends": null,
      "splits": null,
      "buybacks": null,
      "debt_to_equity": 0.44917218683298293,
      "current_ratio": 1.5990538692813143,
      "operating_margin": 13.718599770199265,
      "net_profit_margin": 9.543425901409169,
      "roe": 4.590413737159168,
      "roa": 2.4414119014951075,
      "debt_to_fcf_ratio": null,
      "ebitda_margin": 14.45224347217735,
      "revenue_growth_yoy": null,
      "ebitda_growth_yoy": null
    },
    {
      "ticker": "AARTIDRUGS.NS",
      "date": "2025-06-30",
      "quarter": "Q2 2025",
      "fiscal_year": 2025,
      "revenue": 5905100000.0,
      "gross_profit": 2171200000.0,
      "operating_income": 593600000.0,
      "ebitda": 743900000.0,
      "net_income": 539100000.0,
      "diluted_eps": null,
      "total_assets": null,
      "total_liabilities": null,
      "total_equity": null,
      "total_debt": null,
      "cash_and_equivalents": null,
      "current_assets": null,
      "current_liabilities": null,
      "operating_cash_flow": null,
      "investing_cash_flow": null,
      "financing_cash_flow": null,
      "free_cash_flow": null,
      "capex": null,
      "pe_ratio": 18.838547,
      "peg_ratio": null,
      "pb_ratio": 2.757615,
      "ps_ratio": 1.5100992,
      "price_target_high": 597.0,
      "price_target_low": 597.0,
      "price_target_avg": 597.0,
      "promoter_holding": 0.60928,
      "institutional_holding": 0,
      "eps_estimate": null,
      "next_earnings_date": null,
      "last_buyback_date": null,
      "dividends": null,
      "splits": null,
      "buybacks": null,
      "debt_to_equity": null,
      "current_ratio": null,
      "operating_margin": 10.05232764898139,
      "net_profit_margin": 9.129396623257861,
      "roe": null,
      "roa": null,
      "debt_to_fcf_ratio": null,
      "ebitda_margin": 12.59758513827031,
      "revenue_growth_yoy": null,
      "ebitda_growth_yoy": null
    },
    {
      "ticker": "AARTIDRUGS.NS",
      "date": "2025-09-30",
      "quarter": "Q3 2025",
      "fiscal_year": 2025,
      "revenue": 6527900000.0,
      "gross_profit": 2445000000.0,
      "operating_income": 680300000.0,
      "ebitda": 843700000.0,
      "net_income": 452800000.0,
      "diluted_eps": null,
      "total_assets": 26122700000.0,
      "total_liabilities": 11436800000.0,
      "total_equity": 14685900000.0,
      "total_debt": 5734900000.0,
      "cash_and_equivalents": 66500000.0,
      "current_assets": 13124200000.0,
      "current_liabilities": 7828600000.0,
      "operating_cash_flow": null,
      "investing_cash_flow": null,
      "financing_cash_flow": null,
      "free_cash_flow": null,
      "capex": null,
      "pe_ratio": 18.838547,
      "peg_ratio": null,
      "pb_ratio": 2.757615,
      "ps_ratio": 1.5100992,
      "price_target_high": 597.0,
      "price_target_low": 597.0,
      "price_target_avg": 597.0,
      "promoter_holding": 0.60928,
      "institutional_holding": 0,
      "eps_estimate": null,
      "next_earnings_date": null,
      "last_buyback_date": null,
      "dividends": null,
      "splits": null,
      "buybacks": null,
      "debt_to_equity": 0.39050381658597705,
      "current_ratio": 1.6764427867051581,
      "operating_margin": 10.421421896781508,
      "net_profit_margin": 6.936380765636728,
      "roe": 3.083229492234048,
      "roa": 1.7333583435096678,
      "debt_to_fcf_ratio": null,
      "ebitda_margin": 12.92452396635978,
      "revenue_growth_yoy": 9.10200056824829,
      "ebitda_growth_yoy": 23.113964686998393
    }
  ]
}